Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
18M
-
Shares change
-
+89.7K
-
Total reported value, excl. options
-
$99.9M
-
Value change
-
+$1.83M
-
Number of buys
-
26
-
Number of sells
-
-24
-
Price
-
$5.55
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q2 2020
68 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q2 2020.
Apyx Medical Corp - Common Stock (APYX) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18M shares
of 35M outstanding shares and own 51.44% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.39M shares), Archon Capital Management LLC (2.48M shares), BlackRock Inc. (2.25M shares), VANGUARD GROUP INC (1.41M shares), PURA VIDA INVESTMENTS, LLC (825K shares), JPMORGAN CHASE & CO (655K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), STATE STREET CORP (600K shares), RENAISSANCE TECHNOLOGIES LLC (582K shares), and Taylor Frigon Capital Management LLC (556K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.